Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOvoca Bio Regulatory News (OVB)

  • There is currently no data for OVB

Issue of Consideration Shares

14 Sep 2007 17:30

Ovoca Gold PLC14 September 2007 Ovoca Gold PLC ("Ovoca" or the "Company") Issue of Consideration Shares Further to the announcement on 13 September 2007, an application has been madeto the London Stock Exchange and the Irish Stock Exchange for 43,007,250ordinary shares of €0.025 each in the issued share capital of the Company ('Ordinary Shares') to be admitted to trading on the AIM and IEX marketsrespectively, with dealing expected to commence on 20 September 2007. TheseOrdinary Shares have been allotted to a number of shareholders of CJSCProspectors Artel Ayax pursuant to the exercise of the Option Agreement, asdefined in the circular distributed to shareholders on 18 May 2006 (the 'OptionAgreement'). As part of this issue, certain directors of the Company willreceive Ordinary Shares. The number of Ordinary Shares being allotted to themand their resultant shareholdings in the Company are as follows: No. Ordinary Resultant Resultant Shares Allotted Holding %Leonid Pavlovich Skoptsov 8,270,625 8,270,625 2.29Yuri Ivanovich Radchenko 8,270,625 8,270,625 2.29 Salyco Trading Co. Limited (1) 14,334,375 61,687,718 17.09Subishico Trading Co (2) 6,063,750 29,692,293 8.23Pickco Trading Co. Limited (3) 6,067,875 45,710,533 12.67 (1) Mikhail Alexandrovich Mogutov is the beneficial shareholder of SalycoTrading Co. Limited. (2) The Saint George Trust, of which Leonid Pavlovich Skoptsov is a directoron the board of trustees and beneficial owner of, is the beneficial shareholderin Subishico Trading Co Limited. (3) Yuri Ivanovich Radchenko is the shareholder of Pickco Trading Co. Limited. At an extraordinary general meeting of the Company held on 7 June 2006, amajority of independent shareholders approved, inter alia, the increase in thepercentage of the issued share capital of the Company owned or controlled by theabove mentioned directors and their concert parties pursuant to the OptionAgreement, without triggering an obligation under the Irish Takeover Rules tomake a general offer for the balance of the issued share capital of the Company. About Ovoca Gold plc: Ovoca Gold Plc is an international exploration company quoted in London (OVG.L)and Dublin (OVX.IR), exploring for precious and base metals in Russia andSweden. For further information, www.ovocagold.com or contact: John O'Connor - Company Secretary, Ovoca Gold plcTel: +353 (0)1 6330523Email: john.oconnor@ovocagold.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
5th Feb 20267:00 amRNSChange of Name
28th Jan 20268:00 amRNSReadmission - Ovoca Bio PLC
28th Jan 20267:00 amRNSFirst Day of Dealings on AIM
27th Jan 20262:32 pmRNSResult of Meeting
31st Dec 20258:00 amRNSSchedule One - Ovoca Bio Plc
31st Dec 20258:00 amRNSSchedule One - Ovoca Bio Plc
31st Dec 20257:00 amRNSNotice of AGM
31st Dec 20257:00 amRNSPublication of Admission Document
31st Dec 20257:00 amRNSPublication of Admission Document
31st Dec 20257:00 amRNSNotice of AGM
13th Nov 20257:00 amRNSChange of Broker
30th Sep 20251:09 pmRNSReplacement Half Year Report
30th Sep 20257:00 amRNSHalf-year Report
26th Jun 20257:00 amRNSPublication of 2024 Annual Report
5th Jun 20257:00 amRNSDelisting from Euronext Growth Exchange
7th May 20257:30 amRNSSuspension - Ovoca Bio plc
7th May 20257:00 amRNSProposed Acquisition, Disposal & Reverse Takeover
3rd Mar 20252:00 pmRNSManagement Changes
18th Dec 20246:00 pmRNSResult of AGM
18th Nov 20247:00 amRNSNotice of AGM
11th Oct 20245:30 pmRNSHolding(s) in Company
9th Oct 20245:45 pmRNSSale of Treasury Shares
25th Sep 20247:00 amRNSHalf-year Report
2nd Sep 20242:30 pmRNSConsultancy Agreement
15th Jul 20247:00 amRNSDirector/PDMR Shareholding
15th Jul 20247:00 amRNSDirectorate Change
28th Jun 20247:00 amRNSAnnual Financial Report
23rd Jan 20247:00 amRNSHolding(s) in Company
1st Dec 202312:00 pmRNSResult of AGM
7th Nov 20239:15 amRNSNotice of AGM
28th Sep 20237:00 amRNSInterim Results
31st Aug 20237:00 amRNSSummary Results of Phase II Study for Orenetide
30th Jun 20237:00 amRNSAnnual Financial Report
12th Jun 20237:00 amRNSUpdate on Completion Timelines for Phase II Study
16th Mar 20234:35 pmRNSPrice Monitoring Extension
16th Mar 20232:05 pmRNSSecond Price Monitoring Extn
16th Mar 20232:00 pmRNSPrice Monitoring Extension
16th Mar 20239:05 amRNSSecond Price Monitoring Extn
16th Mar 20239:00 amRNSPrice Monitoring Extension
8th Mar 20237:00 amRNSDisposal of Russian Assets
14th Feb 20234:41 pmRNSSecond Price Monitoring Extn
14th Feb 20234:35 pmRNSPrice Monitoring Extension
14th Feb 20232:05 pmRNSSecond Price Monitoring Extn
14th Feb 20232:00 pmRNSPrice Monitoring Extension
13th Feb 20239:00 amRNSPrice Monitoring Extension
13th Jan 202311:05 amRNSSecond Price Monitoring Extn
13th Jan 202311:00 amRNSPrice Monitoring Extension
28th Oct 20227:00 amRNSResult of AGM
6th Oct 20222:30 pmRNSNotice of AGM
30th Sep 20227:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.